Search
Supernus Pharmaceuticals Inc
SUPNAdd to Watchlist
43.390USD
-0.360-0.82%
Close 09-23 16:00（ET）
2.52BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-0.82%
5 Days
+4.86%
1 Month
-5.37%
6 Months
-11.90%
Year to Date
-12.70%
1 Year
-7.35%
Key Figures
43.660Open
44.458High
52.03KVolume
LossP/E TTM
5.17P/E Dynamic
--Dividend TTM
0.09%Turnover Ratio
43.750Prev. Close
43.140Low
2.27MTurnover
34.10P/E Static
2.44P/B
0.00%Div Yield TTM
-2.04%ROA
59.68052wk High
0.07Volume Ratio
73.86MNet Profit
58.04MShares
-0.5110EPS TTM
0.55Beta
-2.75%ROE
40.51052wk Low
3.71%Amplitude
73.07%Gross Margin
2.52BMarket Cap
0.94Reward/Risk
2.25%Risk Rate
More news coming soon, stay tuned...
Supernus Pharmaceuticals Inc's Score
0.01vs previous score
Forecast8.00
Financial Health8.23
Technical3.17
Valuation Dimensions9.21
Institutional Confidence10.00
Risk Assessment6.50
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Supernus Pharmaceuticals Inc Technical Analysis
Technical Indicators
Buy
Summary
Neutral
Moving Average
Neutral
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-1.01/0.42
Revenue / Forecast
219.06M/204.96M
Supernus Pharmaceuticals Inc Profile
SectorPharmaceuticals
Ticker SymbolSUPN
Number of employees674
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 13.47% |
| Millennium Management LLC | 5.65% |
| Vanguard Portfolio Management, LLC | 5.58% |
| Armistice Capital LLC | 4.76% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 48.46% |
| Investment Advisor/Hedge Fund | 26.81% |
| Hedge Fund | 21.60% |
| Individual Investor | 4.46% |
Related Instruments
-1.64%
-0.01%
-0.05%
-1.88%
+1.01%
-2.99%
-1.01%
-0.85%
-3.12%
+0.90%
+0.26%
-1.77%
-1.20%
-2.00%
-1.99%
-0.26%
-0.25%
-0.74%
-1.86%
-0.35%Popular Instruments
51390.700
-99.300 (-0.19%)
30371.500
-106.400 (-0.35%)
7684.400
-22.600 (-0.29%)
14290.000
-132.000 (-0.92%)
65643.000
-486.000 (-0.73%)
6270.700
-19.300 (-0.31%)
91.123
-1.367 (-1.48%)
337.020
-2.730 (-0.80%)
225.510
-3.360 (-1.47%)
4283.880
-2.360 (-0.06%)
FAQs
What is the current price of Supernus Pharmaceuticals Inc (SUPN)?
The current price of Supernus Pharmaceuticals Inc (SUPN) is 43.39.
What is the symbol of Supernus Pharmaceuticals Inc?
The ticker symbol of Supernus Pharmaceuticals Inc is SUPN.
What is the 52-week high of Supernus Pharmaceuticals Inc?
The 52-week high of Supernus Pharmaceuticals Inc is 59.68.
What is the 52-week low of Supernus Pharmaceuticals Inc?
The 52-week low of Supernus Pharmaceuticals Inc is 40.51.
What is the market capitalization of Supernus Pharmaceuticals Inc?
The market capitalization of Supernus Pharmaceuticals Inc is 2.52B.
Is Supernus Pharmaceuticals Inc (SUPN) currently rated as Buy, Hold, or Sell?
According to analysts, Supernus Pharmaceuticals Inc (SUPN) has an overall rating of Buy, with a price target of 62.60.
What is the Earnings Per Share (EPS TTM) of Supernus Pharmaceuticals Inc (SUPN)?
The Earnings Per Share (EPS TTM) of Supernus Pharmaceuticals Inc (SUPN) is -0.51.